報價延遲最少15分鐘:2026/03/09 22:00 EDT
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
117.11 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
7.28/10.11
|
|
企業價值
333.03B
|
| 資產負債 |
|
每股賬面淨值
21.28
|
| 現金流量 |
|
現金流量率
0.06
|
| 損益表 |
|
收益
65.01B
|
|
每股收益
23.99
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographicalperspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines). |
